Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
PLoS One. 2011;6(11):e26617. doi: 10.1371/journal.pone.0026617. Epub 2011 Nov 1.
Well balanced novelty seeking and exploration are fundamental behaviours for survival and are found to be dysfunctional in several psychiatric disorders. Recent studies suggest that the endocannabinoid (eCB) system is an important control system for investigatory drive. Pharmacological treatment of rodents with cannabinergic drugs results in altered social and object investigation. Interestingly, contradictory results have been obtained, depending on the treatment, drug concentration and experimental conditions. The cannabinoid type 1 (CB1) receptor, a central component of the eCB system, is predominantly found at the synapses of two opposing neuronal populations, i.e. on inhibitory GABAergic and excitatory glutamatergic neurons. In the present study, using different transgenic mouse lines, we aimed at investigating the impact of CB1 receptor inactivation in glutamatergic or GABAergic neurons on investigatory behaviour. We evaluated animate (interaction partner) and inanimate (object) exploratory behaviour in three different paradigms. We show that exploration was increased when CB1 receptor was deleted from cortical and striatal GABAergic neurons. No effect was observed when CB1 receptor was deleted specifically from dopamine receptor D1-expressing striatal GABAergic medium spiny neurons. In contrast, deletion of CB1 receptor from cortical glutamatergic neurons resulted in a decreased exploration. Thus, our results indicate that exploratory behaviour is accurately balanced in both, the social and non-social context, by the eCB system via CB1 receptor activation on cortical glutamatergic and GABAergic neurons. In addition, the results could explain the contradictory findings of previous pharmacological studies and could further suggest a possibility to readjust an imbalance in exploratory behaviour observed in psychiatric disorders.
平衡的新奇寻求和探索是生存的基本行为,在几种精神障碍中被发现是功能失调的。最近的研究表明,内源性大麻素(eCB)系统是探究驱动的重要控制系统。用大麻素类药物对啮齿动物进行药理学治疗会导致社交和物体探索发生改变。有趣的是,取决于治疗、药物浓度和实验条件,会得到相反的结果。大麻素 1 型(CB1)受体是 eCB 系统的核心组成部分,主要存在于两种相反神经元群体的突触上,即抑制性 GABA 能神经元和兴奋性谷氨酸能神经元。在本研究中,我们使用不同的转基因小鼠系,旨在研究 CB1 受体在谷氨酸能或 GABA 能神经元中的失活对探究行为的影响。我们在三个不同的范式中评估了有生命的(互动伙伴)和无生命的(物体)探索行为。我们表明,当 CB1 受体从皮质和纹状体 GABA 能神经元中缺失时,探索增加。当 CB1 受体特异性从多巴胺受体 D1 表达的纹状体 GABA 能中间神经元中缺失时,没有观察到影响。相比之下,当 CB1 受体从皮质谷氨酸能神经元中缺失时,探索减少。因此,我们的结果表明,内源性大麻素系统通过 CB1 受体在皮质谷氨酸能和 GABA 能神经元上的激活,在社会和非社会环境中准确平衡探索行为。此外,这些结果可以解释先前药理学研究的矛盾发现,并进一步表明有可能调整精神障碍中观察到的探索行为失衡。